The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs

Chemico-Biological Interactions

Volumn 111-112, Issue , 1998, Pages 255-262

  Lazo, John S ^a   Kuo, Shiu Ming ^a   Woo, Elizabeth S ^a   Pitt, Bruce R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant; Apoptosis; Metallothionein; Thiols

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTARABINE; GLUTATHIONE; MELPHALAN; METALLOTHIONEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER; CELL METABOLISM; CYTOTOXICITY; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW;

EID: 17744409665     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00165-8     Document Type: Article

References (35)

1. Kagi J.H.R. Evolution, structure and chemical activity of class I metallothioneins: An overview. Suzuki K.T., Imura N., Kimura M. Metallothionein III: Biological Roles and Medical Implications. 1993;29-56 Birkhäuser, Basel.
2. Woo E.S., Monks A., Watkins S.C., Wang A.S., Lazo J.S. Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor Panel. Cancer Chemother. Pharmacol. 41:1997;61-68.
3. Banerjee D., Onosaka S., Cherian M.G. Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology. 24:1982;95-105.
4. Lazo J.S., Pitt B.R. Metallothioneins and cell death by anticancer drugs. Cho A.K., Blaschke T.F., Loh H.H., Way J.L. Annual Review of Pharmacology and Toxicology. 1995;635-653 Annual Reviews, Palo Alto, CA.
5. Kasahara K., Fujiwara Y., Nishio K., Ohmori T., Sugimoto Y., Komiya K., Matsuda T., Saijo N. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res. 51:1991;3237-3242.
6. Kuo S.-M., Kondo Y., DeFilippo J.M., Ernstoff M.S., Bahnson R.R., Lazo J.S. Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserum. Toxicol. Appl. Pharmacol. 125:1994;104-110.
7. Kelley S.L., Basu A., Teicher B.A., Hacker M.P., Hamer D.H., Lazo J.S. Overexpression of metallothionein confers resistance to anticancer drugs. Science. 241:1988;1813-1815.
8. Kaina B., Lohrer H., Karin M., Herrlich P. Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents. Proc. Natl. Acad. Sci. USA. 87:1990;2710-3714.
9. Schwarz M.A., Lazo J.S., Yalowich J.C., Allen W.P., Whitmore M., Bergonia H.A., Tzeng E., Billiar T.R., Robbins P.D., Lancaster J.R. Jr., Pitt B.R. Metallothionein protects against the cytotoxic and DNA damaging effects of nitric oxide. Proc. Natl. Acad. Sci. USA. 92:1995;4452-4456.
10. Kondo Y., Woo E., Michalska A.E., Choo A.C., Lazo J.S. Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res. 55:1995;2021-2023.
11. Lazo J.S., Kondo Y., Dellapiazza D., Michalska A.E., Choo K.H.A., Pitt B.R. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J. Biol. Chem. 270:1995;5506-5510.
12. Ochi T., Otsuka F., Takahashi K., Ohsawa M. Glutathione and metallothioneins as cellular defense against cadminum toxicity in cultured Chinese hamster cells. Chem. Biol. Interact. 65:1988;1-14.
13. Ferreira A.M., Ciriolo M.R., Marcocci L., Rotilio G. Copper(I) transfer into metallothionein mediated by glutathione. Biochem. J. 292:1993;673-676.
14. Brouwer M., Hoexum-Brouwer B.T., Cashon R.E. A putative glutathione-binding site in CdZn-metallothionein identified by equilibrium binding and molecular-modelling studies. Biochem. J. 294:1993;219-225.
15. D.H. Petering, A. Quesada, M. Dughish, S. Krull, T. Gan, D. Lemkuil, A. Pattanaik, R.W. Byrnes, M. Savas, H. Whelan, C.F. Shaw III, Metallothionein in tumor and host: Intersections of zinc metabolism, the stress response and tumor therapy, in: K.T. Suzuki, N. Imura, M. Kimura (Eds.), Metallothionein III: Biological Roles and Medical Implications, Birkhäuser, Basel, 1993, pp. 329-346.
16. Yu X., Wu Z., Fenselau C. Covalent sequestration of melphalan by metallothionein and selective alkylation of cysteines. Biochemistry. 34:1995;3377-3385.
17. Zaia J., Jiang L., Han M.S., Tabb J.R., Wu Z., Fabris D., Fenselau C. A binding site for chlorambucil on metallothionein. Biochemistry. 35:1996;2830-2835.
18. Kondo Y., Kuo S.-M., Watkins S.C., Lazo J.S. Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines. Cancer Res. 55:1995;474-477.
19. Leyshon-Sorland K., Morkrid L., Rugstrad H.E. Metallothionein: a protein conferring resistance in vitro to tumor necrosis factor. Cancer Res. 53:1993;4874-4880.
20. K.T. Tamai, E.B. Gralla, L.M. Ellerby, V. J.S. Valentine, D.J. Thiele, Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase, Proc. Natl. Acad. Sci. USA 90 (1993) 8013-8017.
21. Zheng H., Liu J., Choo K.H.A., Michalska A.E., Klaassen C.D. Metallothionein-I and -II knock-out mice are sensitive to cadmium-induced liver mRNA expression of c-jun and p53. Toxicol. Appl. Pharmacol. 136:1996;229-235.
22. Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Radic. Biol. Med. 14:1993;325-337.
23. Schwarz M.A., Lazo J.S., Yalowich J.C., Reynolds I., Kagan V.E., Tyurin V., Kim T.-M., Watkins S.C., Pitt B.R. Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity. J. Biol. Chem. 269:1994;15238-15243.
24. B.R. Pitt, M. Schwarz, E.S. Woo, E. Yee, K. Wasserloos, S. Tran, W. Weng, R.J. Mannix, S.A. Watkins, Y.Y. Tyurina, V.A. Tyurin, V.E. Kagan, J.S. Lazo, Overexpression of metallothionein decreases the sensivitiy of pulmonary endothelial cells to oxidant injury, Am. J. Physiol. Cell Mol. Physiol. (1997) in press.
25. 2 with sulfhydryl groups in HL-60 cells. Arch. Biochem. Biophys. 334:1996;241-250.
26. Buttke T.M., Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol. Today. 15:1994;7-10.
27. Johnson T.M., Yu Z.-X., Ferrans V.J., Lowenstein R.A., Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;11848-11852.
28. Greenlund L.J., Deckwerth T.L., Johnson E.M. Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
29. Mayer M., Noble M. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc. Natl. Acad. Sci. USA. 91:1994;7496-7500.
30. Lin K.I., Lee S.H., Narayanan R., Baraban J.M., Hardwick J.M., Ratan R.R. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-κ-B. J. Cell Biol. 131:1995;1149-1161.
31. Y. Kondo, J.M. Rusnak, D.G. Hoyt, C.E. Settineri, B.R. Pitt, J.S. Lazo, Enhanced apoptosis in metallothionein null cells, Mol. Pharmacol. (in press).
32. Abdel-Mageed A.B., Agrawal K.C. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther. 4:1997;199-207.
33. Bellomo G., Vairetti M., Stivala L., Mirabelli F., Richelmi P., Orenius S. Demonstration of nuclear compartmentalization of glutathione in hepatocytes. Proc. Natl. Acad. Sci. USA. 89:1992;4412-4416.
34. Michaud N., Goldfarb D.S. Most nuclear proteins are imported by a single pathway. Exp. Cell Res. 208:1993;128-136.
35. Woo E.S., Kondo Y., Watkins S.C., Hoyt D.G., Lazo J.S. Nucleophilic distribution of metallothionein tumor cells. Exp. Cell Res. 224:1996;365-371.